SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer, will participate in a panel discussion at TD Cowen's 44th Annual Health Care Conference.
Additionally, the company announced an upcoming presentation at the 2024 American Academy of Dermatology (AAD) Annual Meeting in San Diego, CA, March 8-12, 2024. The oral presentation will focus on preclinical ANB032 (BTLA agonist) data supporting the modulation of dendritic cell (DC) maturation and function as a novel mechanism to address atopic dermatitis pathophysiology.
Investor Conference Details
- Event – TD Cowen's 44th Annual Health Care Conference
- Format – Corporate panel discussion and one-on-one investor meetings
- Panel Title – Inflammation & Immunology Corporate Panel Discussion
- Date and Time – Tuesday, March 5, 2024 at 2:10pm ET ...